We have come across this as well. However, since the projects that were submitted and/or funded did not, from the PI's perspective, particularly raise issues of intellectual property, we did not even attempt to challenge it. Our sense, however, was that it would not be an easy challenge as this condition was apparently built into their basic, non-negoitable terms and conditions and principles of funding. If anyone has had any experience and/or success challenging this term, I too would appreciate hearing about it.
John R. Baumann, Ph.D.
Director
Office of Sponsored Programs & Research Support
University of Missouri -- Kansas City
5100 Rockhill Road
Kansas City, MO 64110
816.235.1303 (v)
816.235.6532 (f)
xxxxxx@umkc.edu -----Original Message-----
From: Amy Hibbard [mailto:xxxxxx@KGI.EDU]
Sent: Tue 5/14/2002 5:38 PM
To: xxxxxx@HRINET.ORG
Cc:
Subject: [RESADM-L] Intellectual property
Hello all-
I'd like to pick your collective brains for a minute about something. I
have a PI who would like to submit a Type G grant to the American Chemical
Society. One of the terms of the grant states, " . . . any patent which is
taken out by or on behalf of the principal investigator or the grantee
institution, and which is derived from research funded in whole or in part
by this grant, shall be dedicated to the public, royalty free." Is this a
standard term, or if not, does it sound acceptable to you?
My knowledge of IP, though increasing, would still fit into a small box.
The award amount is small ($35K for two years), and I would hate to sign the
PI's rights away, particularly for such a small amount.
Thanks for your input on what, I hope, will turn out to be a case of the
worry-warts,
-Amy
Discovery consists in seeing what everyone else has seen and thinking what
no one else has thought.
-Albert von Nagyrapolt
Amy Hibbard
Grants Administrator
Keck Graduate Institute of Applied Life Sciences
535 Watson Drive, Claremont, CA 91711
T: (909) 607-9313 / 607-7855
F: (909) 607-8086
xxxxxx@kgi.edu
www.kgi.edu
======================================================================
Instructions on how to use the RESADM-L Mailing List, including
subscription information and a web-searchable archive, are available
via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================